INIS
patients
100%
skin
78%
management
63%
tumors
59%
neoplasms
59%
dendrites
54%
texas
54%
mycobacterium
54%
side effects
54%
spectra
54%
leukemia
54%
gulf coast
54%
lupus
54%
tumor cells
54%
wounds
54%
surgery
39%
metastases
36%
breasts
36%
cancer
36%
stains
36%
drugs
36%
populations
30%
biopsy
28%
bacillus
27%
therapy
27%
range
23%
diseases
18%
antibiotics
18%
metabolites
18%
women
18%
morphology
12%
melanomas
12%
males
12%
malignancies
12%
trauma
9%
environmental exposure
9%
increasing
9%
evaluation
9%
sun
6%
collisions
6%
sheets
6%
epidermis
6%
carcinomas
6%
melanin
6%
pigments
6%
keratin
6%
defects
5%
bones
5%
comparative evaluations
5%
nose
5%
Medicine and Dentistry
Patient
64%
Case Report
54%
Hand Foot Syndrome
54%
Neoplasm
54%
Mycobacterium Avium-Intracellulare Infection
54%
Chronic Myelomonocytic Leukemia
54%
Dendritic Cell Sarcoma
54%
Diagnosis
43%
Culture
32%
Acid Fast Bacterium
32%
Specimen
21%
Therapeutic Procedure
21%
Surgery
21%
Skin Biopsy
21%
Infection
21%
Smear
21%
Cells
16%
Postoperative Management
15%
Antibiotics
10%
Cancer
10%
Skin
10%
Disease
10%
Male
10%
Clinical Feature
10%
Nodular Melanoma
10%
Antibiotic Resistance
10%
Patient Referral
10%
Incidence
10%
Evaluation Study
10%
Environmental Exposure
10%
Mycobacterium abscessus
10%
Morphology
10%
Metastatic Breast Cancer
9%
Prodrug
9%
Cell Population
5%
Histogenesis
5%
Examination
5%
Epithelioid Cell
5%
Squamous Cell Carcinoma
5%
Middle Age
5%
Prognosis
5%
Scalp
5%
Lesion
5%
Epithelial Cell
5%
Face
5%
Biopsy
5%
Melanin
5%
Epidermis
5%
Keratin
5%
Pigment
5%
Keyphrases
Biosynthetic Wound Dressings
54%
Porcine Xenograft
54%
Palmar-plantar Erythrodysesthesia
54%
Squamomelanocytic Tumor
54%
Indeterminate Dendritic Cell Tumor
54%
Biological Dressings
40%
Wound Management
27%
Postoperative Management
27%
Second-intention Healing
13%
Wound Depth
13%
Medical Comorbidity
13%
Tumor Margin
13%
Large Wound
13%
Micrographic Surgery
13%
Nasal Defect
13%
Wound Reconstruction
13%
Multidrug Treatment
10%
Offending Drugs
10%
Cutaneous Abnormalities
10%
Dermatological Adverse Effects
10%
Therapy-systemic
10%
Xeloda
10%
Collision Tumor
10%
Keratosis
10%
Papulonodules
10%
Collision Type
10%